Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Lecouturier

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Behavioral Medicine|May 9, 2009
Improving professional practice in the disclosure of a diagnosis of dementia: a modeling experiment to evaluate a theory-based interventionMartin P Eccles, Jill Francis, Robbie Foy, et al.
Evidence & Policy : a Journal of Research, Debate and Practice|June 25, 2025
The critical factors in producing high quality and policy-relevant research: insights from international behavioural science unitsJan Lecouturier, Ivo Vlaev, Paul Chadwick, et al.
Health Technology Assessment (Winchester, England)|September 21, 2018
Standing frames for children with cerebral palsy: a mixed-methods feasibility studyJane Goodwin, Jan Lecouturier, Anna Basu, et al.
Journal of Cancer Survivorship : Research and Practice|April 10, 2025
Development of the SCNS-TARGET: a new tool to assess unmet needs in cancer patients utilising immuno-, biological or precision therapiesLisa Crowe, Morven C Brown, Jan Lecouturier, et al.
BMJ Open|September 19, 2022
Safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm studySarah Dunn, Victoria Brocklebank, Andrew Bryant, et al.
Trials|November 11, 2018
ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trialRebecca Forbes, Ased Ali, Alaa Abouhajar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 22, 2025
Cost-effectiveness of lifelong eculizumab versus disease monitoring of aHUSGiovany Orozco-Leal, Luke Vale, Yemi Oluboyede, et al.
Health Technology Assessment (Winchester, England)|January 25, 2021
Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCTJanet A Wilson, Deborah D Stocken, Gillian C Watson, et al.
The Lancet Regional Health. Europe|January 19, 2026
Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trialAndrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
BMJ (Clinical Research Ed.)|March 10, 2022
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trialChris Harding, Helen Mossop, Tara Homer, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Behavioral Medicine|May 9, 2009
Improving professional practice in the disclosure of a diagnosis of dementia: a modeling experiment to evaluate a theory-based interventionMartin P Eccles, Jill Francis, Robbie Foy, et al.
Evidence & Policy : a Journal of Research, Debate and Practice|June 25, 2025
The critical factors in producing high quality and policy-relevant research: insights from international behavioural science unitsJan Lecouturier, Ivo Vlaev, Paul Chadwick, et al.
Health Technology Assessment (Winchester, England)|September 21, 2018
Standing frames for children with cerebral palsy: a mixed-methods feasibility studyJane Goodwin, Jan Lecouturier, Anna Basu, et al.
Journal of Cancer Survivorship : Research and Practice|April 10, 2025
Development of the SCNS-TARGET: a new tool to assess unmet needs in cancer patients utilising immuno-, biological or precision therapiesLisa Crowe, Morven C Brown, Jan Lecouturier, et al.
BMJ Open|September 19, 2022
Safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm studySarah Dunn, Victoria Brocklebank, Andrew Bryant, et al.
Trials|November 11, 2018
ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trialRebecca Forbes, Ased Ali, Alaa Abouhajar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 22, 2025
Cost-effectiveness of lifelong eculizumab versus disease monitoring of aHUSGiovany Orozco-Leal, Luke Vale, Yemi Oluboyede, et al.
Health Technology Assessment (Winchester, England)|January 25, 2021
Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCTJanet A Wilson, Deborah D Stocken, Gillian C Watson, et al.
The Lancet Regional Health. Europe|January 19, 2026
Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trialAndrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
BMJ (Clinical Research Ed.)|March 10, 2022
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trialChris Harding, Helen Mossop, Tara Homer, et al.
Pageof 5